Skip to content

Early Stepping Verticalization in ICU for ABI Patients

Effectiveness of a Very Early Stepping Verticalization Protocol in Severe Acquired Brain Injured Patients: a Randomized Pilot Study in ICU

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02828371
Enrollment
40
Registered
2016-07-11
Start date
2015-01-31
Completion date
2015-12-31
Last updated
2016-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Injury, Consciousness Disorders

Brief summary

Verticalization was reported to improve the level of arousal and awareness in patients with severe acquired brain injury (ABI) and to be safe in ICU. The investigators evaluated the effectiveness of a very early stepping verticalization protocol on the functional and neurological outcome of patients affected by disorder of consciousness due to ABI. Consecutive patients with Vegetative State or Minimally Conscious State were enrolled in ICU on the third day after an ABI. They were randomized to undergo conventional physiotherapy alone or associated to fifteen 30-minute sessions of verticalization, using a tilt table with robotic stepping device. Once stabilized, patients were transferred to a Neurorehabilitation unit for an individualized treatment. Outcome measures were assessed on the third day from the injury (T0), at ICU discharge (T1) and at Rehab discharge (T2).

Interventions

After patient positioning, the slope of the tilt table was gradually increased from 0° to 20°, 40° and then 60° in a time span of nine minutes. The stepping frequency was set at 20 steps/min for the entire treatment. Cardiovascular and respiratory parameters were continuously monitored. The net time of the session was 30 minutes

OTHERconventional mobilization

in-bed physiotherapy (mobilization exercises in supine and sitting position on bed, without out-of-bed mobilization nor verticalization)

Sponsors

Ospedale Generale Di Zona Moriggia-Pelascini
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Glasgow Coma Scale (GCS) ≤8 for ≥24h from the event; * diagnosis of vegetative state or minimally conscious state on the third day after the injury; * adequate pulmonary gas exchanging function; * stable hemodynamics

Exclusion criteria

* sedation; * unstable intracranial pressure (ICP); * cerebral perfusion pressure (CPP) \<60 mmHg; * fractures or skin lesions in thorax, abdomen or lower limbs; * deep vein thrombosis; * body weight \>130 kg; height \>210 cm.

Design outcomes

Primary

MeasureTime frame
Coma Recovery Scale changethrough study completion, average 18 weeks
Glasgow Coma Scale changethrough study completion, average 18 weeks
Levels of Cognitive Functioning changethrough study completion, average 18 weeks
Disability Rating Scale changethrough study completion, average 18 weeks

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026